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ABSTRACT. 3-Methyl-4H-isoxazol-5-one was synthesized at room temperature by simple stirring method from 
ethyl acetoacetate and hydroxylamine hydrochloride in aqueous medium and coupled with diazotized substituted 
amine to form series of 4-(substituted phenylazo)-3-methyl-4H-isoxazol-5-ones through green chemistry. All the 
compounds formed were characterized by IR, 1H and 13C NMR spectroscopy, MS and elemental analysis. Crystal 
structure of novel 4-(4-fluorophenylazo)-3-methyl-4H-isoxazol-5-one was determined by the X-ray diffraction. 
Antibacterial and antifungal activity was studied against Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus, Staphylococcus pyogenus and Candida albicans, Aspergillus niger, Aspergillus clavatus, 
respectively. All synthesized compounds were found to be active against a gram-positive bacterium 
Staphylococcus aureus. Two compounds showed antifungal activity against Candida albicans close to standard 
greseofulvin. 
  
KEY WORDS: Azo dyes, Substituted amines, Antibacterial and antifungal activity, X-ray diffraction, 
Spectroscopy, Green chemistry 
INTRODUCTION 
 
Azo dyes are the most widely used class of coloring materials because of their fruitful 
applications in various fields of science and technology [1-3] and also for their interesting 
structural and physicochemical properties [4-6]. Azo dyes are synthesized by diazotization of 
aromatic amines and coupling reagent, which include one or more azo groups (–N=N–) attached 
to one or more aromatic moieties [7]. Currently, heteroarylazoisoxazol compounds have 
received the attention of many research groups [8] because of their wide spread potential 
applications in fields of catalysis [9], cancer treatment and as antibacterial and antiviral agents, 
agricultural fungicides as well as other biological uses [10-12]. Intramolecular N–H∙∙∙O 
hydrogen bonding study assisted by resonance for 1-ketone-2-arylhydrazones derivatives 
suggest that heterocyclic five member ring introduces geometrical constraint which hinders the 
strengthening of hydrogen bond [13]. Tautomerism and spectroscopic properties of some 
heteroarylazoisoxazolone dyes were studied earlier [14]. With these objects in view we focus on 
the synthesis and antimicrobial activity of 4-(substituted phenylazo)-3-methyl-4H-isoxazol-5-
one azo dyes.  
EXPERIMENTAL 
 
All the starting materials and solvents were purchased from commercial sources and were used 
without further purification. Melting points were determined in open capillaries using electro 
thermal melting point apparatus and are uncorrected. Progress of reactions was monitored by 
TLC. Infrared (IR) spectra (4000–600 cm–1) of the samples were recorded using a Perkin–Elmer 
Spectrum 100, equipped with a Specac Golden Gate Diamond ATR as a solid sample support. 
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1H NMR spectra were recorded with a Bruker Avance III 500 nuclear magnetic resonance 
spectrometer with TMS as internal reference. 13C NMR spectra were recorded with a Bruker 
Avance III 500 spectrometer at 125 MHz and were referenced against the central line of the 
solvent signal (CDCl3 triplet at 77.0 ppm or DMSO-d6 septet at 39.5 ppm). MS spectra were 
recorded with an Agilent 6624 Accurate Mass TOF LC/MS instrument (ESI ionization). 
Single-crystal X-ray diffraction data for 6c∙0.3H2O were collected on an Agilent 
Technologies SuperNova Dual diffractometer with the Atlas detector using monochromated 
Mo-Kα radiation (λ = 0.71073 Å) at room temperature. The data were processed using CrysAlis 
Pro. [15]. The structure was solved by direct methods using the program Superflip [16] and 
refined on F2 using full-matrix least-squares procedures using SHELXL2014 [17]. All non-
hydrogen atoms were refined anisotropically. Hydrogen atoms were readily located in a 
difference Fourier maps and were subsequently treated as riding atoms in geometrically 
idealized positions, with C–H = 0.93 (aromatic) or 0.96 Å (CH3), N–H = 0.86 Å and with 
Uiso(H) = kUeq(C or N), where k = 1.5 for methyl groups, which were permitted to rotate but not 
to tilt, and 1.2 for all other H atoms. The water H-atoms were refined with a distance restraint 
and with Uiso(H) = 1.5Ueq(O). Initially, the occupation factor for a water solvate molecule was 
refined, but was set as fixed at 0.30 in the final stage of the refinement. Structure was refined as 
a twin. Crystallographic data are listed in Table 1. 
 
Determination of minimal inhibition concentrations by micro broth dilution for antibacterial 
and antifungal activity  
 
All the synthesized drugs were used for antibacterial test procedures. All necessary controls like 
drug control, vehicle control, agar control, organism control, known antibacterial drugs control, 
all MTCC cultures were tested against above mentioned known and unknown drugs. Mueller 
Hinton broth was used as nutrient medium to grow and dilute the drug suspension for the test 
bacteria. Inoculum size for test strain was adjusted to 108Cfu [Colony Forming Unit] per 
milliliter by comparing the turbidity. Common standard strains were used for screening of 
antibacterial and antifungal activities: The strains were procured from Institute of Microbial 
Technology, Chandigarh: E. coli (MTCC443), P. aeruginosa (MTCC1688), S. aureus 
(MTCC96), S. pyogenus (MTCC442), C. albicans (MTCC227), A. niger (MTCC282), A. 
clavatus (MTCC1323). DMSO was used as diluents / vehicle to get desired concentration of 
drugs to test upon standard bacterial strains. 
The main advantage of the ‘Broth Dilution Method’ for minimal inhibition concentration 
(MIC) determination lies in the fact that it can readily be converted to determine the MIC as 
well [18-22]. Serial dilutions were prepared in primary and secondary screening. The control 
tube containing no antibiotic is immediately sub cultured (before inoculation) by spreading a 
loopful evenly over a quarter of plate of medium suitable for the growth of the test organism and 
put for incubation at 37 oC overnight. The tubes are then incubated overnight. The MIC of the 
control organism is read to check the accuracy of the drug concentrations. The lowest 
concentration inhibiting growth of the organism is recorded as the MIC. The amount of growth 
from the control tube before incubation is compared [23]. 
Each synthesized drug was diluted obtaining 2000 μg/mL concentration, as a stock solution. 
In primary screening 1000, 500, and 250 μg/mL concentrations of the synthesized drugs were 
taken. The active synthesized drugs found in this primary screening were further tested in a 
second set of dilution against all microorganisms. The drugs found active in primary screening 
were similarly diluted to obtain 200, 100, 50, 25, 12.5, 6.250 μg/mL end concentrations. The 
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General procedure for synthesis of 3-methyl-4-H-isoxazol-5-one 
 
Hydroxylamine hydrochloride (1.041 g, 15 mmol) was dissolved in 20 mL of water and cooled 
to about 10 oC, added ethyl acetoacetate (1.95 g, 15 mmol). The mixture was shaken thoroughly 
in absence of any catalyst till the appearance of pale yellow color solution of 3-methyl-4H-
isoxazol-5-one [24]. 
 
General procedure for synthesis of 4-(substituted phenylazo)-3-methyl-4H-isoxazol-5-one azo 
dyes  
 
Substituted amine 4a–e (15 mmol) were dissolved in dilute HCl (1.5 mL in 15 mL water) and 
cooled in an ice bath to 0–5 oC. The reaction mixture was added to the solution of sodium nitrite 
(1.043 g, 15 mmol in 15 mL of water) and 0.01 M HCl (15 mL) at about 0–5 oC with continuous 
stirring to give yellow colored solution 5a–e. To this solution, equimolar amount of cooled 3-
methyl-4H-isoxazol-5-one solution was added in ice bath with continuous stirring for 30 min to 
get yellow orange colored precipitate. The pH of reaction mixture was maintained between 5 
and 6. The reaction mixture was kept overnight at about 15 oC for the completion of the reaction. 
The precipitate obtained 6a–e was washed with cold water, dried and recrystallized using 
ethanol. Crystals of 6c suitable for single crystal XRD analysis were obtained by slow 




3-Methyl-4-phenylazo-4H-isoxazol-5-one (6a). Yellow solid, yield: 2.45 g (85%), m.p.: 170 oC,  
Rf 0.214 (EtOH). Elemental analysis: found %, C 59.26; H 4.42; N 20.73; C10H9N3O2 (203.20 
g/mol). Calculated, % C 59.11; H 4.46; N 20.68;MS (ESI+) m/z: 204.0767 (MH+), HRMS: 
found, m/z: 204.0768; C10H9N3O2 calculated, m/z: 204.0767. IR (cm
–1): 3209 (NH), 1708 (C=O), 
1570 (CH=N), 1482 (C=C), 1277 (C–O); 1H NMR (500 MHz, CDCl3, δ ppm): 2.26 (s, 3H,      
3-CH3), 7.37–7.19 (m, 5H, Ar-H), 12.60 (s, 1H, -NH); 
13C NMR, δ ppm, CDCl3: 10.3, 116.1, 
121.1, 126.7, 129.8, 140.4, 159.4, 164.9. 
 
4-(4-Chloro-phenylazo)-3-methyl-4H-isoxazol-5-one (6b). Yellow solid, yield: 2.79 g (82%), 
m.p.: 155 oC, Rf 0.224 (EtOH). Elemental analysis: found %, C 50.57; H 3.47; N 17.31; 
C10H8ClN3O2 (237.64 g/mol). Calculated, % C 50.54; H 3.39; N 17.68. MS (ESI+) m/z: 
238.0377 (MH+), HRMS: found, m/z: 238.0378; C10H9N3O2 calculated, m/z: 238.0377. IR (cm
–
1): 3204 (NH), 1739 (C=O), 1554 (CH=N), 1477 (C=C), 1220 (C–O). 1H NMR (500 MHz, 
CDCl3, δ ppm): 2.26 (s, 3H, -CH3 isoxazol), 7.35–7.28 (m, 4H, Ar-H), 12.57 (s, 1H, -NH), 
13C 
NMR (125 MHz, CDCl3, δ ppm): 10.3, 117.2, 130.0, 132.0, 139.0, 159.3, 164.8. 
 
4-(4-Fluorophenylazo)-3-methyl-4H-isoxazol-5-one (6c). Orange yellow solid, yield: 2.60 g 
(83%), m.p.: 160 oC, Rf 0.217 (EtOH). Elemental analysis: found %, C 54.60; H 3.25; N 18.80; 
C10H8FN3O2 (221.19 g/mol). Calculated, % C 54.30; H 3.65; N 19.00. MS, (ESI+) m/z: 
222.0671 (MH+), HRMS: found, m/z: 222.0673; C10H8FN3O2 calculated, m/z: 222.0671. IR  
(cm–1): 3199 (NH), 1714 (C=O), 1565 (CH=N), 1493 (C=C), 1215 (C–O). 1H NMR (500 MHz, 
CDCl3, δ ppm): 2.26 (s, 3H, -CH3isoxazol), 7.09–7.06 (m, 2H, Ar-H), 7.35–7.32 (m, 2H, Ar-H), 
12.62 (s, 1H, -NH). 13C NMR (125 MHz, CDCl3, δ ppm):  10.2, 116.7, 136.7, 159.3, 160.1, 
162.1, 164.0.  
 
4-(3-Methyl-5-oxo-4,5-dihydroisoxazol-4-ylazo)benzenesulfonamide (6d). Orange yellow solid, 
yield 3.20 g (79%), m.p. 240 oC, Rf 0.260 (EtOH). Elemental analysis found, %: C 42.40; H 
3.41; N 19.40; C10H10N4O4S (282.28 g/mol). Calculated, % C 42.55; H 3.57; N, 19.85.MS, 
(ESI+) m/z: 283.0491 (MH+), HRMS: found, m/z: 283.0495; C10H10N4O4S calculated, m/z: 
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283.0491. IR (cm–1): 3317 (NH), 1719 (C=O), 1570 (CH=N), 1482 (C=C), 1246 (C–O). 1H 
NMR (500 MHz, CDCl3, δ ppm): 2.29 (s, 3H, -CH3 isoxazol), 4.71 (s, 2H, -NH2), 7.46–7.44 (d, 
2H, Ar-H), 7.94–7.92 (d, 2H, Ar-H), 12.56 (s, 1H, -NH). 13C NMR (125 MHz, DMSO, δ ppm): 
10.6, 117.2, 122.7, 127.5, 141.2, 144.4, 160.5, 162.4. 
 
4-(3-Acetylphenylazo)-3-methyl-4H-isoxazol-5-one (6e). Orange solid, yield: 2.76 g (79%), 
m.p.: 210 oC, Rf 0.251 (EtOH). Elemental analysis found, %: C 59.42; H 3.20; N 16.77; 
C12H11N3O3 (245.23 g/mol). Calculated, % C 58.77; H 4.52; N 17.17,  MS, (ESI+) m/z: 
246.0871 (MH+), HRMS: found, m/z: 246.0873; C12H11N3O3 calculated, m/z: 246.0871. IR    
(cm–1): 3204 (NH), 1734 (C=O), 1549 (CH=N), 1431 (C=C), 1272 (C–O). 1H NMR (500 MHz, 
CDCl3, δ ppm): 2.29 (s, 3H, -CH3 isoxazol), 2.51 (s, 3H, -COCH3), 7.92–7.47 (m, 4H, Ar-H), 
12.63 (s, 1H, -NH). 13C NMR (125 MHz, CDCl3, δ ppm): 10.3, 26.7, 115.3, 120.2, 126.3, 130.2, 
138.6, 140.9, 159.4, 164.7, 196.9. 
RESULTS AND DISCUSSION 
 
A series of 4-(substituted phenylazo)-3-methyl-4-H-isoxazol-5-one azo dyes were obtained from 
easily available, economically feasible chemicals like ethyl acetoacetate, hydroxylamine 
hydrochloride and some substituted amines by environmentally benign, green route in aqueous 
medium without using any catalyst. In the first step the reaction of ethyl acetoacetate (1) and 
hydroxylamine hydrochloride (2) resulted in the formation of oxime, which on further ring 
closure formed 3-methyl-4H-isoxazol-5-one (3) (Scheme 1). Electron withdrawing effect of N 
atom in 3-methyl-4H-isoxazol-5-one along with electron donating effect of O atom and presence 
of electron releasing methyl and keto groups makes it more reactive [15]. In the second step 
diazotization of substituted amine 4a–e was carried out in the presence of sodium nitrite and 
hydrochloric acidwhich then coupled with active hydrogen atom of isoxazol nucleus under cold 

































a: R = H,  b: R = 4-Cl,  c: R = 4-F,  d: R = 4-SO2NH2, e: R = 3-COCH3 
Scheme 1: Synthesis of 4-(substituted phenylazo)-3-methyl-4H-isoxazol-5-one azo dyes. 
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All compounds 6a–e show singlet for NH proton in the range of 12.50–12.60 ppm. 
Multiplets for aromatic ring were observed between 7–8 ppm. A singlet for three protons in the 
range of 2.26–2.29 is attributed to CH3 group of isoxazol. Compound 6d shows a singlet for two 
protons of NH2 group related to sulphanilamide moiety at 4.71 ppm and compound 6e show a 
singlet for three protons related to COCH3 group at 2.51 ppm. 
13C NMR study of 6a–e shows a 
singlet at about 10.24–10.56 ppm for CH3 group of isoxazol, about 160–165 ppm for C=O group 
of isoxazol, compound 6e shows singlet at 197 ppm for C=O group of acetophenone and at 26 
ppm for CH3 group of acetophenone. The IR spectrum of compound 6a–e showed characteristic 
(-NH) absorption band in the region 3024-3317 cm-1, (C=O) absorption band in the region 








Figure 2. Molecular structure and atom numbering scheme for 6c. Elipsoid Probability are 
drawn at the 50% level and hydrogen bonding of  C4–H4A∙∙∙O2 and C10–H10∙∙∙O1 is 
indicated by blue dashed lines. 
 
Single-crystal X-ray structures of 4-(4-fluorophenylazo)-3-methyl-4H-isoxazol-5-one 
(6c∙0.3H2O) was determined (Figure 2, Table 1). Table 3 and 4 describes significant bond 
distances and bond angles. All the bond lengths and bond angles of compounds are within 
normal ranges for this type of structure as reported earlier [13]. Molecule 6c is almost planar, 
maximum deviation from the mean plane described by all atoms of 6c is –0.132(3) Å for atom 
C10. The dihedral angle between the isoxazolone and phenyl rings is 7.81(18)o. In the crystal 
structure bond distances indicates that the isoxazolone ring contains one double bond, i.e.      
C1-N1. Also, atoms C2 and N2 are connected through double bond and intramolecular          
N3–H3∙∙∙O2 hydrogen bonding is present between NH group and the carbonyl group of the 
isoxazole ring. A water solvate molecule present in the crystal lattice with 30% occupancy 
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forms O3–H3A∙∙∙O2 hydrogen bond with two adjacent molecules of 6c. Furthermore, molecules 
are linked into chains via C4–H4A···O2 interactions between methyl group of isoxazole ring 
and carbonyl oxygen atom of isoxazole moiety of the adjacent molecule and C10–H10···O1 
interactions between the phenyl moiety and the oxygen atom of isoxazole moiety of the adjacent 
molecule (Figure 3). 
 
 
Figure 3. Chain formation generated by C4–H4A∙∙∙O2 and C10–H10∙∙∙O1 interactions. 
Hydrogen-bonds are indicated by blue dashed lines. 
 
Table 1. Crystallographic data for 4-(4-fluorophenylazo)-3-methyl-4H-isoxazol-5-one (6c∙0.3H2O). 
 
Compound code  6c∙0.3H2O 
CCDC number 1561281 
Molecular formula C10H8.6FN3O2.3 
Molecular weight 226.60 
Crystal System Orthorhombic 
Space group Fdd2 





V (Å3) 4074.2(5) 
Dcalc (g cm
–3) 1.478 
μ (mm–1) 0.120 
F(000) 1872 
Reflections collected 8741 
Parameters 155 
Goodness-of-fit on F2 1.069 
R1, wR2 [I > 2σ(I)]
a 0.0407, 0.0939 
R1, wR2 (all data)
b 0.0560, 0.1023 
Δρmin, Δρmax (e Å
–3) –0.172, 0.13 
 
Table 2. Hydrogen bond geometry of 6c (Å and °). 
 
D–H···A D–H (Å) H∙∙∙A (Å) D···A (Å) D–H∙∙∙A (°) Symmetry code 
N3–H3∙∙∙O2 0.86 2.23 2.882(3) 132.4 x, y, z 
O3–H3A∙∙∙O2 0.82(2) 2.20(3) 3.007(4) 169(8) x, y, z 
C4–H4A∙∙∙O2 0.96 2.56 3.371(4) 142.8 –x + 3/4, y – 1/4, z + 1/4    
C10–H10∙∙∙O1 0.93 2.55 3.379(3) 149.4 –x + 3/4, y + 1/4, z – 1/4 
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Table 3. Significant bond distances. 
 
Sr. No. Bond Distance (Å) 
1 F1 C8 1.363(3) 
2 O1 C3 1.359(3) 
3 O1 N1 1.470(3) 
4 O2 C3 1.213(4) 
5 N1 C1 1.292(3) 
6 N2 N3 1.306(3) 
7 N2 C2 1.311(3) 
8 N3 C5 1.412(3) 
 
Table 4. Significant bond angles. 
 
Sr. No. Bond Angle (°) 
1 C3 O1 N1 109.2(2) 
2 C1 N1 O1 106.6(2) 
3 N3 N2 C2 118.4(2) 
4 N2 N3 C5 120.0(2) 
5 N1 C1 C2 111.9(3) 
6 N1 C1 C4 120.9(3) 
7 C2 C1 C4 127.2(2) 
8 N2 C2 C1 125.2(2) 
9 N2 C2 C3 129.1(2) 
10 C1 C2 C3 105.6(2) 
11 O2 C3 O1 122.1(3) 
12 O2 C3 C2 131.1(3) 
13 O1 C3 C2 106.7(2) 
 
All synthesized compounds 6a–e were screened for antibacterial and antifungal study 
against E. coli, P. aeruginosa, S. aureus and S. pyogenus as bacterial strain and C. albicans, A. 
niger, A. clavatus as fungal strain. All synthesized compounds 6a–e showed antibacterial 
activity against S. aureus. Compound 6c and 6e showed antibacterial activity against E. coli 
whereas compound 6b showed antibacterial activity against S. pyogenus close to activity of 
standard ampicillin (Table 5). It was found that compounds 6b and 6e show antifungal activity 
against C. albicans close to standard greseofulvin (Table 6). 
 
Table 5. Antibacterial activity study of 6a–e with standard drugs. 
 
Minimal inhibition concentration (μg/mL) 








1 6a 125 200 100 125 
2 6b  200 500 200 100 
3 6c 62.5 250 200 200 
4 6d 200 250 100 200 
5 6e 100 250 250 250 
9 Gentamycin 0.05 1 0.25 0.5 
10 Ampicillin 100 - 250 100 
11 Chloramphenicol 50 50 50 50 
12 Ciprofloxacin 25 25 50 50 
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The method of synthesis of 6a–e is aqueous phased, environmentally friendly and gives product 
easily in good yield without using any hazardous chemicals. Spectroscopic study of 6a–e and X-
ray crystallographic study of 6c shows azo dye formation with tautemerism to retain aromaticity 
of isoxazole ring. All synthesized compounds showed antibacterial activity against S. aureus 
close to standard ampicillin. Compounds 6c and 6e showed antibacterial activity against E. coli 
close to ampicillin and 6b and 6e showed antifungal activity against C. albicans close to 
gresiofulvin. The crystal structure of 6c shows hydrogen bonding interaction with water 
molecule. Oxygen atom attached to isoxazole ring shows intermolecular as well as 
intramolecular hydrogen bonding.  
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